Cancer & Disease Research
How one company aims to make bedside cell therapies a reality
SQZ Biotech is developing high-throughput technology that can manufacture novel cell therapy products in under 24 hours. Founder and CEO Armon Sharei, PhD, spoke with ScienceBoard.net recently at Biotech Week Boston 2021. Read More
Nanopore sensor quickly detects infectious viruses
Scientists have designed a nanopore-based sensor that can detect the presence and infectiousness of a virus in a sample within minutes, according to a new study published in Science Advances on September 22. The new method successfully detected SARS-CoV-2, positioning it as a speedier, less fussy alternative to other tests. Read More
AI model predicts oxygen needs of COVID-19 patients
Researchers have trained an artificial intelligence (AI) model to predict the future oxygen needs of symptomatic patients with COVID-19, according to a study published in Nature Medicine on September 15. Read More
NanoCellect raises $35M for new development
NanoCellect Biomedical has raised $35 million this year in funding rounds to accelerate the company's commercial growth plans and new product development goals. Read More
5 ways social media can make drug development more patient-centered
Insights gleaned from analyzing social media can facilitate patient-centered drug development and help spur innovation in drug discovery, according to a paper published online recently in Drug Discovery Today. Read More
Vaccine for tooth decay? It's not science fiction, says NIH
A vaccine for caries could be possible under a new division of the U.S. National Institutes of Health (NIH) that has been tasked with using "crazy, bold ideas" to prevent and cure disease. Health leaders introduced the proposed agency at a September 9 meeting of the National Institute of Dental and Craniofacial Research. Read More
How challenging risky ideas fuels the research ecosystem
If you knew that an experiment would fail, would it be worthwhile to conduct if it had the potential to challenge fundamental hypotheses about science? In a recent interview with ScienceBoard.net, world-renowned Stanford University scientist and serial entrepreneur Stephen Quake, PhD, discussed the value of basic research and his contributions to the biomedical field. Read More
Researchers figure out how the immune system sparks cell death
Immunologists have discovered how the innate immune system launches a multifaceted attack against invaders through the use of multiple immune sensors. The work was published in Nature on September 1. Read More
McMaster, Sartorius partner on improving biomanufacturing
Sartorius Stedim Biotech and McMaster University, which is located in Hamilton, Ontario, Canada, plan to collaborate on an effort to improve advanced manufacturing processes for antibody and virus-based treatments for diseases like COVID-19 and cancer. Read More
New sensor-based test could lead to fast, cheap antibiotic susceptibility testing
Scientists have developed a new method for monitoring bacterial responses to antibiotics that could enable personalized antibiotic therapies. The test uses sensors to reduce time and costs while increasing the portability for antibiotic susceptibility testing of patient samples. The results of the study were published recently in Scientific Reports. Read More
Conferences
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter